Stacie M. Jones, M.D., is Professor and Chief of Allergy and Immunology at the University of Arkansas for Medical Sciences (UAMS) and Arkansas Children’s Hospital (ACH). Dr. Jones holds the Dr. and Mrs. Leeman H. King Endowed Chair in Pediatric Allergy. She is a board-certified Specialist in Pediatrics and Allergy and Immunology and currently serves as Director of the Food Allergy Program and Co-Director of the Lung Cell Biology Laboratory at the Arkansas Children’s Research Institute (ACRI).
TrialSite News recently covered Dr. Jones’ participation in the nearly two-decade research effort that led to the commercialization of the first peanut allergy drug called Palforzia.
Her research focuses on both clinical and translational investigation of food allergy, eosinophilic esophagitis, and asthma. Dr. Jones is the principal investigator at ACRI for the both the NIH-funded Consortium for Food Allergy Research (CoFAR) and the NIH-funded Immune Tolerance Network IMPACT Study and is involved in multiple food allergy therapeutic trials through an active collaborative research network. Dr. Jones also has a long-standing research interest in mechanisms of airway, hyper-responsiveness in asthma, and mechanisms of disease for eosinophilic esophagitis, and along with her collaborators, is actively investigating these questions in human tissue platforms. Her bibliography can be found here.